BCL2-driven malignant transformation is one of the principal pathophysiological mechanisms of GCB-subtype DLBCL, and constitutive activation of the NF-κB pathway is the hallmark of ABC-subtype DLBCL15–17. Here, NFKB1 is linked to diffuse large B-cell lymphoma.